S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Cidara Therapeutics, Inc.

CDTX 医疗健康
$221.38 +$0.06 (0.03%)
Market Cap: $6.97 B
Gurus Holding
8
Popularity Rank
#708
% of Shares Held
10.21%
Net Activity (Q4 2025)
+$162.08 M

Guru Ownership Trend

Guru Analysis for Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics, Inc. (CDTX), a key player in the 医疗健康 sector, continues to attract institutional attention.

As of Q4 2025, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $712.25 M.

Top institutional holders include 杰富瑞集团 and 史蒂夫·科恩.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $162.08 M net inflow during the quarter.

Recent activity highlights 杰富瑞集团 who increased their stake by 110.0%.

Key Holders

Top 5 by Value

$169.32 M
$151.12 M
$100.72 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$162.08 M
Total Buy Value
New Buys 2
Additions 3
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
0
Net Buyers
5

FAQs for Cidara Therapeutics, Inc. (CDTX)

Major holders include 杰富瑞集团 ($169.32 M), 史蒂夫·科恩 ($151.12 M), 李·安斯利 ($100.72 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 3.22 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $162.08 M, with 5 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in CDTX during the most recent reporting period.

Yes, 2 managers opened new positions in CDTX, and 3 increased their existing holdings. The total reported buy value was $162.08 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.87% Add 110.0% 766,520 $169.32 M Q4 2025
0.25% Add 3.3% 1,578,069 $151.12 M Q3 2025
1.08% Add 9.2% 455,978 $100.72 M Q4 2025
0.70% New Buy 275,000 $60.74 M Q4 2025
0.04% Add 6.0% 110,560 $24.42 M Q4 2025
0.03% New Buy 12,500 $2.76 M Q4 2025
0.00% Add 37.0% 14,944 $1.43 M Q3 2025
0.00% New Buy 3,758 $359,866 Q3 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form